Drug recall · November 13, 2024
Dapsone Gel 7.5% recall
Why: Crystallization
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.
- Lots / codes
Lots T401151, Exp, 06/30/2026; T400806, Exp 03/31/2026
- Quantity
- 6048 pumps
- Company
- Viona Pharmaceuticals Inc, Cranford, NJ
- Distribution
- USA Nationwide
- Initiated
- October 29, 2024 · Voluntary: Firm initiated
- Classified
- November 5, 2024
- Reported
- November 13, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dapsone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.